Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers

The modulation of the host innate immune system is a well-established carcinogenesis feature of several tumors, including human papillomavirus- (HPV-) related cancers. This virus is able to interrupt the initial events of the immune response, including the expression of Toll-like receptors (TLRs), c...

Full description

Saved in:
Bibliographic Details
Main Authors: Marconi Rego Barros, Talita Helena Araújo de Oliveira, Cristiane Moutinho Lagos de Melo, Aldo Venuti, Antonio Carlos de Freitas
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/2912671
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850167433041543168
author Marconi Rego Barros
Talita Helena Araújo de Oliveira
Cristiane Moutinho Lagos de Melo
Aldo Venuti
Antonio Carlos de Freitas
author_facet Marconi Rego Barros
Talita Helena Araújo de Oliveira
Cristiane Moutinho Lagos de Melo
Aldo Venuti
Antonio Carlos de Freitas
author_sort Marconi Rego Barros
collection DOAJ
description The modulation of the host innate immune system is a well-established carcinogenesis feature of several tumors, including human papillomavirus- (HPV-) related cancers. This virus is able to interrupt the initial events of the immune response, including the expression of Toll-like receptors (TLRs), cytokines, and inflammation. Both TLRs and cytokines play a central role in HPV recognition, cell maturation and differentiation as well as immune signalling. Therefore, the imbalance of this sensitive control of the immune response is a key factor for developing immunotherapies, which strengthen the host immune system to accomplish an efficient defence against HPV and HPV-infected cells. Based on this, the review is aimed at exposing the HPV immune evasion mechanisms involving TLRs and cytokines and at discussing existing and potential immunotherapeutic TLR- and cytokine-related tools.
format Article
id doaj-art-d9ea9a0104cd4b928a5726ffc2cacd10
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-d9ea9a0104cd4b928a5726ffc2cacd102025-08-20T02:21:13ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/29126712912671Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated CancersMarconi Rego Barros0Talita Helena Araújo de Oliveira1Cristiane Moutinho Lagos de Melo2Aldo Venuti3Antonio Carlos de Freitas4Laboratory of Molecular Studies and Experimental Therapy (LEMTE), Department of Genetics, Center of Biological Sciences, Federal University of Pernambuco, Av. Prof Moraes Rego, 1235 Cidade Universitária 50670-901 Recife, PE, BrazilLaboratory of Molecular Studies and Experimental Therapy (LEMTE), Department of Genetics, Center of Biological Sciences, Federal University of Pernambuco, Av. Prof Moraes Rego, 1235 Cidade Universitária 50670-901 Recife, PE, BrazilLaboratory of Immunological and Antitumor Analysis (LAIA), Department of Antibiotics, Center of Biological Sciences, Federal University of Pernambuco, Av. Prof Artur de Sá, s/n, Cidade Universitária 50740-525 Recife, PE, BrazilTumor Immunology and Immunotherapy Unit, Department of Research, Advanced Diagnostic and Technological Innovation, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Roma, ItalyLaboratory of Molecular Studies and Experimental Therapy (LEMTE), Department of Genetics, Center of Biological Sciences, Federal University of Pernambuco, Av. Prof Moraes Rego, 1235 Cidade Universitária 50670-901 Recife, PE, BrazilThe modulation of the host innate immune system is a well-established carcinogenesis feature of several tumors, including human papillomavirus- (HPV-) related cancers. This virus is able to interrupt the initial events of the immune response, including the expression of Toll-like receptors (TLRs), cytokines, and inflammation. Both TLRs and cytokines play a central role in HPV recognition, cell maturation and differentiation as well as immune signalling. Therefore, the imbalance of this sensitive control of the immune response is a key factor for developing immunotherapies, which strengthen the host immune system to accomplish an efficient defence against HPV and HPV-infected cells. Based on this, the review is aimed at exposing the HPV immune evasion mechanisms involving TLRs and cytokines and at discussing existing and potential immunotherapeutic TLR- and cytokine-related tools.http://dx.doi.org/10.1155/2018/2912671
spellingShingle Marconi Rego Barros
Talita Helena Araújo de Oliveira
Cristiane Moutinho Lagos de Melo
Aldo Venuti
Antonio Carlos de Freitas
Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
Journal of Immunology Research
title Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
title_full Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
title_fullStr Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
title_full_unstemmed Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
title_short Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
title_sort viral modulation of tlrs and cytokines and the related immunotherapies for hpv associated cancers
url http://dx.doi.org/10.1155/2018/2912671
work_keys_str_mv AT marconiregobarros viralmodulationoftlrsandcytokinesandtherelatedimmunotherapiesforhpvassociatedcancers
AT talitahelenaaraujodeoliveira viralmodulationoftlrsandcytokinesandtherelatedimmunotherapiesforhpvassociatedcancers
AT cristianemoutinholagosdemelo viralmodulationoftlrsandcytokinesandtherelatedimmunotherapiesforhpvassociatedcancers
AT aldovenuti viralmodulationoftlrsandcytokinesandtherelatedimmunotherapiesforhpvassociatedcancers
AT antoniocarlosdefreitas viralmodulationoftlrsandcytokinesandtherelatedimmunotherapiesforhpvassociatedcancers